Braveheart Bio, Inc. BRVE

IPO NASDAQ
IPO Score
IPO Date
Aug 05, 2026
Recommendation
Dividend Power Score
Day's Range
$21.38$22.22
Latest Close
Volume
--
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)

06/30/2026 06/30/2025
Total Cash And Short-Term Investments 52.44% --
Total Receivables -- --
Inventory -- --
Prepaid Expenses 23.79% --
Finance Division Loans and Leases Current -- --
Total Finance Division Other Current Assets -- --
Other Current Assets -- --
Total Current Assets 52.27% --

Total Current Assets 52.27% --
Net Property, Plant & Equipment -14.40% --
Long-term Investments -- --
Goodwill -- --
Total Other Intangibles -- --
Finance Div Loans & Leases LT -- --
Total Finance Div Other LT Assets -- --
Total Other Assets 4,015.71% --
Total Assets 55.06% --

Total Accounts Payable -65.53% --
Total Accrued Expenses 183.62% --
Short-term Debt -- --
Current Portion of Long-Term Debt/Capital Leases -- --
Finance Division Debt Current 1.07% --
Total Finance Division Other Current Liabilities -- --
Total Other Current Liabilities -- --
Total Current Liabilities -9.44% --

Total Current Liabilities -9.44% --
Long-Term Debt -- --
Short-term Debt -- --
Capital Leases -32.65% --
Finance Division Debt Non Current -- --
Total Finance Division Other Non Current Liabilities -- --
Total Other Liabilities -3.37% --
Total Liabilities -10.04% --

Common Stock & APIC -99.95% --
Retained Earnings -19.39% --
Treasury Stock & Other -- --
Total Common Equity -22.34% --

Preferred Stock Redeemable -- --
Preferred Stock Non Redeemable -- --
Preferred Stock Convertible 42.46% --
Preferred Stock, Others -- --
Total Preferred Equity 42.46% --

Total Common Equity -22.34% --
Total Preferred Equity 42.46% --
Total Minority Interest -- --
Total Equity 64.51% --